Biotechnology
HeiQ unveils HeiQ Skin Care - a probiotics-infused textile technology
ZÜRICH, Nov. 21, 2023 /PRNewswire/ -- HeiQ introduces a 100% biobased and long-lasting cosmetic finishing technology for textiles to the market.The newest addition to the HeiQ portfolio harnesses the power of active probiotics and selected prebiotics to enhance the skin microbiome, turning the hu...
2023-11-21 16:00
1321
JUMPSTARTER 2023 Tech by the Harbour Successfully Concludes
Allegrow Biotech in Biotech and Life Science Industry crowned champion of JUMPSTARTER 2023 Global Pitch Competition Two-week public event attracts over 100,000 participants HONG KONG, Nov. 21, 2023 /PRNewswire/ -- JUMPSTARTER, organized by Alibaba Hong Kong Entrepreneurs Fund ("AEF"), held its f...
2023-11-21 15:23
1462
ST Pharm Presented '100-Day Expedite Strategy', Preparedness and Proactive Measures for Future Pandemic at Korea-CEPI R&D Workshop
SEOUL, South Korea, Nov. 20, 2023 /PRNewswire/ -- Nov. 21, 2023 local time, ST Pharm announced 'Rapid Preparedness of Pandemic Vaccine in 100 Days using ST Pharm's own mRNA Platform Technology' at the Korea-CEPI R&D Workshop in World Bio Summit 2023, organized by Korea Health Industry Development...
2023-11-21 12:00
1148
CARsgen Announces Formation of its Clinical Advisory Board
SHANGHAI, Nov. 20, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces the formation of its Clinical Advisory Board. This highly regarded pa...
2023-11-20 21:50
2361
Metabolon Collaborates with Trajan on Microsampling Solutions for Metabolomics Research
The power of advanced metabolomic analytical techniques can now be applied to a broader array of diverse academic and commercial life science research MORRISVILLE, N.C. and TORRANCE, Calif., Nov. 20, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions adva...
2023-11-20 21:03
1025
Viva Biotech Secures Approximately US$ 210 Million Funding
HONG KONG, Nov. 20, 2023 /PRNewswire/ -- On November 20, 2023, Viva Biotech Holdings Group (1873. HK) announced thatit completed a funding round, securing approximatelyUS$210 million and bringing in the strategic investors, Temasek, Highlight Capital (HLC), and True Light. Following this transact...
2023-11-20 20:04
2321
Porton Advanced and Ascle Therapeutics Reached a Strategic Partnership to Promote the Application of NK Cells in Cancer Prevention, Beauty, and Anti-aging
SUZHOU, China, Nov. 20, 2023 /PRNewswire/ -- On November 20, 2023, Porton Advanced announced a strategic partnership with Ascle Therapeutics to jointly develop and produce NK cells, assist in the development and innovation in gene and cell therapy, and accelerate the application of NK cells in ca...
2023-11-20 20:00
951
First Subject Enrolled in Phase 1 Study of MRX-5
SHANGHAI, Nov. 20, 2023 /PRNewswire/ -- Recently, Shanghai MicuRx Pharmaceuticals Co., Ltd. (hereinafter referred to as ＂MicuRx＂) announced that its proprietary antibiotic MRX-5, has enrolled its first subject in the first Phase I clinical trial inAustralia. MRX-5 is a new type of benzodiazepine...
2023-11-20 18:34
1202
GCCL Wins Top 10 Bioanalytical Services Providers in APAC 2023
Recognized for its global-quality sample analysis services based on various analytical platforms YONGIN, South Korea, Nov. 20, 2023 /PRNewswire/ -- GCCL, a Korean clinical trial sample analysis company, announced onNovember 20th that it has been selected as the Top 10 Bioanalytical Services Prov...
2023-11-20 14:39
1162
Sanyou's "STAL Platform" is a significant advancement in the field of drug discovery.
SHANGHAI, Nov. 17, 2023 /PRNewswire/ -- Sanyou's "STAL Innovative Biologics Drug Discovery Platform" is a significant advancement in the field of drug discovery. This cutting-edge platform enables the screening of thousands of innovative lead molecules against a common target, surpassing the capa...
2023-11-18 08:00
2793
CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update
Conference call webcast is scheduled for November 22 at 9 a.m. ET.
SINGAPORE, Nov. 17, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited
2023-11-17 22:21
3544
The Institute of Human Genetics, Polish Academy of Sciences (IHG PAS) is Live on SOPHiA GENETICS
The SOPHiA DDM™ Platform used by IHG PAS to advance its research of male infertility BOSTON and ROLLE, Switzerland, Nov. 17, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that the Institute of Human Gene...
2023-11-17 21:02
1408
Singleron Biotechnologies announces two co-authored abstracts at the American Society of Hematology conference
Using single cell multi-omics analysis to predict treatment outcome, develop
disease prognostics and track patient responses to CAR T therapies
COLOGNE, Germany, Nov. 17, 2023 /PRNewswire/ -- Singleron Biotechnologies
2023-11-17 17:58
1132
WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange
HONG KONG, Nov. 17, 2023 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization ("CRDMO") focused on antibody drug conjugates ("ADC") and the broader bioconjugate market, listed on the...
2023-11-17 14:00
2536
Over 86 percent of Thai and Indonesian Women Consider Thalassemia Screening after Learning about Associated Health Risks
Thai (91.2%) and Indonesian (86.6%) women consider screening after learning
about health risks and costs which is higher than the global average of 84.5%
BANGKOK, Nov. 17, 2023 /PRNewswire/ -- According to Thailand's Ministry of
Public Health
2023-11-17 08:22
1717
Antengene Presents Encouraging Clinical Data from Four Pipeline Programs at the 2023 R&D Day
* Clinical programs, including ATG-101 (PD-L1/4-1BB bispecific antibody), ATG-022 (Claudin 18.2 antibody-drug conjugate), and ATG-037 (oral CD73 inhibitor) have shown clinical responses in cancer patients with advanced diseases. * ATG-008 (dual mTORC1/2 inhibitor) continued showing strong cli...
2023-11-17 08:00
1819
Complete Genomics opens $3.2 million manufacturing facility at its San Jose headquarters
SAN JOSE, Calif., Nov. 16, 2023 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, today announced plans for the opening of a$3.2 million manufacturing facility within its headquarters in San Jose, California. The facility, scheduled to open inMarch 2024, will give Comple...
2023-11-16 22:00
1365
Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objective in ACcomplisH China Phase 2 Trial
SHANGHAI, Nov. 16, 2023 /PRNewswire/ -- VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutical company focused on endocrine diseases, is pleased to announce the topline results from the ACcomplisH China Phase 2 Trial in children with achondroplasia (ACH) aged 2 to 10 years. In the trial, ...
2023-11-16 22:00
1230
ACROBiosystems launches GMP-grade DLL4 Protein to accelerate stem cell manufacturing
NEWARK, Del., Nov. 16, 2023 /PRNewswire/ -- ACROBiosystems, a global cornerstone of the pharmaceutical industry committed to offering innovative tools and solutions, recently announces the launch of GMP grade DLL4. GMP grade DLL4 is a recombinant, soluble form of Delta-like Ligand 4, or DLL4, ...
2023-11-16 20:08
1137
CU Medicine develops novel microbiome technology MOZAICTM for faecal microbiota transplantation
Enhancing treatment success for Clostridioides difficile infections to over 90% HONG KONG, Nov. 16, 2023 /PRNewswire/ -- Clostridioides difficile infection (CDI) is a common hospital-acquired infection worldwide. Recurrence and mortality rates have been reported to be up to 35% and 40%, respectiv...
2023-11-16 17:26
1442
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 292 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 290 media titles]
2024-04-22 06:00
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
8930
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
2024-04-18 21:26
8836
Animated Life in Yunnan
2024-04-18 14:00
7824
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7736
IQAX eBL Wins Prestigious APTFF Trade Facilitation Innovation Award 2024
2024-04-18 10:36
3903